The apolipoprotein E ε4 allele and the response to tacrine therapy in Alzheimer's disease

European Journal of Neurology

Volumn 7, Issue 3, 2000, Pages 255-258

  Rigaud, A S ^a   Traykov, L ^a   Caputo, L ^a   Guelfi, M C ^a   Latour, F ^a   Couderc, R ^a   Moulin, F ^a   De Rotrou, J ^a   Forette, F ^a   Boller, F ^a  

^a Paris Descartes University   (France)

Author keywords

Alzheimer's disease; Anticholinesterase; Apolipoprotein E; Dementia; Tacrine; 4 allele

Indexed keywords

APOLIPOPROTEIN E; CHOLINESTERASE INHIBITOR; TACRINE; APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; CLINICAL TRIAL; COGNITION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GENETICS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SEXUAL DEVELOPMENT;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHOLINESTERASE INHIBITORS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SEX CHARACTERISTICS; TACRINE;

EID: 0034351513     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2000.00073.x     Document Type: Article

References (15)

1. Pharmacokinetics of tetrahydroaminoacridine: Relations to clinical and biochemical effects in Alzheimer patients
2. Direct phenotyping of human Apolipoprotein E in plasma: Application to population frequency distribution in Paris (France)
3. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease
4. Tacrine: A pharmacological review
5. Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease
6. Lewy-body dementia and responsiveness to cholinesterase inhibitors: A paradigm for heterogeneity of Alzheimer's disease?
7. Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's Disease
8. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on AIzheimer's Disease
9. The Alzheimer's Disease Assessment Scale: An instrument for assessing treatment efficacy
10. Apolipoprotein E4, cholinergic integrity, synaptic plasticity and Alzheimer's disease
11. Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease
12. Apolipoprotein E and Alzheimer's disease: State of the field after two years
13. Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease
14. 11C] methyl-tetrahydroaminoacridine distribution and kinetics in healthy human subjects